Gland Pharma Limited (GLAND) — Capital Reinvestment Ratio
Gland Pharma Limited (GLAND) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs5.93 Billion) in capital expenditures (Rs1.94 Billion). See net asset quality index of Gland Pharma Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gland Pharma Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Gland Pharma Limited's Capital Reinvestment Ratio across 9 annual periods. Check Gland Pharma Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Gland Pharma Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Gland Pharma Limited from 2017 to 2025. For live market cap and broader valuation context, see Gland Pharma Limited market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | Rs9.15 Billion | Rs3.85 Billion | ▲ +7.5% |
| 2024 | 0.39x | Rs9.97 Billion | Rs3.90 Billion | ▼ -36.2% |
| 2023 | 0.61x | Rs3.64 Billion | Rs2.23 Billion | ▼ -7.2% |
| 2022 | 0.66x | Rs7.91 Billion | Rs5.22 Billion | ▲ +74.6% |
| 2021 | 0.38x | Rs6.05 Billion | Rs2.29 Billion | ▲ +36.2% |
| 2020 | 0.28x | Rs7.01 Billion | Rs1.95 Billion | ▼ -62.1% |
| 2019 | 0.73x | Rs1.85 Billion | Rs1.36 Billion | ▲ +73.9% |
| 2018 | 0.42x | Rs2.02 Billion | Rs851.75 Million | ▲ +72.8% |
| 2017 | 0.24x | Rs4.76 Billion | Rs1.16 Billion | — |